Ключевые слова
Как цитировать
Аннотация
Отдельную группу больных, перенесших радикальную простатэктомию, составляют пациенты с изолированным рецидивом рака в лимфатических узлах, ограниченных регионарными и/или забрюшинными лимфатическими узлами. В качестве одного из вариантов лечения данной группы пациентов может быть применена лимфаденэктомия открытым или лапароскопическим (робот-ассистированным) доступом. проведенный анализ литературы указывает на увеличение общей выживаемости данной группы пациентов при проведении лимфаденэктомии. Доступные методы визуализации, такие как мультипараметрическая магнитно-резонансная томография и по-зитронно-эмиссионная томография, позволяют более точно идентифицировать поражение лимфатических узлов у пациентов с биохимическим рецидивом рака простаты после радикальной простатэктомии.Библиографические ссылки
Abdollah F., Briganti A., Montorsi F. et al. Contemporary Role of Salvage Lymphadenectomy in Patients with Recurrence Following Radical Prostatectomy // Europ. Urol. - 2015. - № 67. - Vol. 5. - P. 839-849.
Castellucci P., Fuccio C., Rubello D. Is there a role for (1) (1)C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase №1.5 ng/ml? // Eur J Nucl Med Mol Imaging. - 2011. - № 38. - P. 55-63.
Ceci F., Castellucci P., Mamede M. (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy // Eur J Nucl Med Mol Imaging. - 2013. - № 40. - P. 149-155.
Coelho R.F., Palmer K.J., Moniz R. et al. Early Complication Rates in a Single-Surgeon Series of 2500 Ro-botic-Assisted Radical Prostatectomies: Report Applying a Standardized Grading System // Eur Urol. - 2010. - Vol. 57. - P. 945-952.
DeJong, J. Pruim, P. Elsinga et al. C-Choline positron emission tomography for the evaluation after treatment of localized prostate cancer // Eur Urol. - 2003. - Vol. 44. - P. 32-39.
Giovacchini G., Picchio M., Briganti A. [11C] Choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging // J Urol. - 2010. - Vol. 184. - P. 938-943.
Giovacchini G., Picchio M., Coradeschi E. Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy // Eur J Nucl Med Mol Imaging. - 2010. - Vol. 37. - P. 301-309.
Giovacchini G., Picchio M., Scattoni V. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy // Eur J Nucl Med Mol Imaging. - 2010. - Vol. 37. - P. 1106-1116
Giovacchini G., Picchio M., Gracia-Parra R. [11C] Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen deprivation therapy // J Nucl Med. - 2014. - Vol. 55. - P. 233-241.
Harisinghani M.G., Barentsz J., Hahn P.F. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer // New Engl J Med. - 2003. - Vol. 348. - P. 2491-2499.
Heesakkers R.A., Hovels A.M., Jager G.J. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study // Lancet Oncol. - 2008. - Vol. 9. - P. 850-856.
Husarik D.B., Miralbell R., Dubs M. Evaluation of [(18) F]-choline PET/CT for staging and restaging of prostate cancer // Eur J Nucl Med Mol Imaging. - 2008. - Vol.
- P. 253-263. Jilg C.A., Rischke H.C., Reske S.N. Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer // J Urol. - 2012. - Vol. - 188. - P. 2190-2197.
Kitajima K., Murphy R.C., Nathan M.A. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil // J Nucl Med. - 2014. - Vol. 55. - P. 223-232.
Krause B.J., Souvatzoglou M., Tuncel M. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer // Eur J Nucl Med Mol Imaging. - 2008. - Vol. 35. - P. 18-23.
Lecouvet F.E., Mouedden J. El, Collette L. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? // Eur Urol. - 2012. - Vol. 62. - P. 68-75.
Mamede M., Ceci F., Castellucci P. The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level №0.5 ng/ml // Clin Nucl Med. - 2013. - Vol. 38. - P. 342-345.
Marzola M.C., Chondrogiannis S., Ferretti A. Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution // Clin Nucl Med. - 2013. - Vol. 38. - P. 26-32.
Mottet, N. Prostate cancer: guidelines / N. Mottet, PJ. Bastian, J. Bellmunt, R.C.N. van den Bergh, M. Bolla, N.J. van Casteren, P. Cornford, S. Joniau, M.D. Mason, V. Matveev, T.H. van der Kwast, H. van der Poel, O. Rouvi re, T. Wiegel. - Netherlands: European Association of Urology, 2016. - 128 рp.
Panebianco V., Sciarra A., Lisi D. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP) // Eur J Radiol. - 2012. - Vol. 81. - P. 700-708.
Picchio M., Messa C., Landoni C. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography // J Urol. - 2003. - Vol. 169. - P. 1337-1340.
Richter J.A., Rodriguez M., Rioja J. Dual tracer 11C-cho-line and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment // Mol Imaging Biol. - 2010. - Vol. 12. - P. 210-217.
Rigatti P., Suardi N., Briganti A. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography // Eur Urol. - 2011. - Vol. 60. - P. 935-943.
Rinnab L., Mottaghy F.M., Simon J. [11C]Choline PET/ CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer: preliminary results of a prospective study // Urol Int. - 2008. - Vol. 81. - P. 191-197.
Schilling D., Schlemmer H.P., Wagner PH. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer // BJU Int. - 2008. - Vol. 102. - P. 446-451.
Suardi N., Porter C.R., Reuther A.M. A nomogram predicting long-term biochemical recurrence after radical prostatectomy // Cancer. - 2008. - Vol. 112. - P. 12541263.
Suardi N., Karnes J., Joniau S., Salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and imaging-detected nodal metastases // J Urol. - 2013. - Vol. 189. - P. 317-318.
Suardi N., Gandaglia G., Gallina A. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years // Eur Urol. - 2015. - Vol. 67. - P. 299-309.
Tilki D., Reich O., Graser A. 18F-Fluoroethylcholine PET/ CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent // Eur Urol. - 2013. - Vol. 63. - P. 792-796.
Wang L., Hricak H., Kattan M.W. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer // AJR Am J Roentgenol. - 2006. - Vol. 186. - P. 743-748.
Winter J., Uphoff R.P., Henke F. Wawroschek. First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy // Urol Int. - 2010. - Vol. 84. - P. 418-423.
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2017